Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Cornea
|
July 19, 2016
Intraocular Lens Calcification After DSEK: A Mechanism and Preventive Technique
Joseph C Lacey, Baljit K Ghatora, Peter J S Foot, et al.
Organic Letters
|
June 12, 2018
Synthetic Studies on the Natural Product Myrsinoic Acid F Reveal Biologically Active Analogues
Jiri Mikusek, Jeremy Nugent, Jas S Ward, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 16, 2022
Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease
Jonathan S Foot, Alberto Buson, Mandar Deodhar, et al.
British Journal of Pharmacology
|
August 7, 2016
The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model
A G Jarnicki, H Schilter, G Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 19, 2012
The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1)
Jonathan S Foot, Mandar Deodhar, Craig I Turner, et al.
Protein Science : a Publication of the Protein Society
|
August 21, 2024
Stabilization of the open conformation οf insulin-regulated aminopeptidase by a novel substrate-selective small-molecule inhibitor
Anastasia Mpakali, Galateia Georgaki, Alberto Buson, et al.
Respiratory Research
|
April 19, 2015
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration
Heidi C Schilter, Adam Collison, Remo C Russo, et al.
Journal of Medicinal Chemistry
|
October 4, 2019
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3
Alison D Findlay, Jonathan S Foot, Alberto Buson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 15, 2013
PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo
Jonathan S Foot, Tin T Yow, Heidi Schilter, et al.
Oncotarget
|
February 16, 2017
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
Joan Chang, Morghan C Lucas, Lidia E Leonte, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Cornea
|
July 19, 2016
Intraocular Lens Calcification After DSEK: A Mechanism and Preventive Technique
Joseph C Lacey, Baljit K Ghatora, Peter J S Foot, et al.
Organic Letters
|
June 12, 2018
Synthetic Studies on the Natural Product Myrsinoic Acid F Reveal Biologically Active Analogues
Jiri Mikusek, Jeremy Nugent, Jas S Ward, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 16, 2022
Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease
Jonathan S Foot, Alberto Buson, Mandar Deodhar, et al.
British Journal of Pharmacology
|
August 7, 2016
The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model
A G Jarnicki, H Schilter, G Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 19, 2012
The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1)
Jonathan S Foot, Mandar Deodhar, Craig I Turner, et al.
Protein Science : a Publication of the Protein Society
|
August 21, 2024
Stabilization of the open conformation οf insulin-regulated aminopeptidase by a novel substrate-selective small-molecule inhibitor
Anastasia Mpakali, Galateia Georgaki, Alberto Buson, et al.
Respiratory Research
|
April 19, 2015
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration
Heidi C Schilter, Adam Collison, Remo C Russo, et al.
Journal of Medicinal Chemistry
|
October 4, 2019
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3
Alison D Findlay, Jonathan S Foot, Alberto Buson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 15, 2013
PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo
Jonathan S Foot, Tin T Yow, Heidi Schilter, et al.
Oncotarget
|
February 16, 2017
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
Joan Chang, Morghan C Lucas, Lidia E Leonte, et al.
Page
of 4